NPM1 and acute myeloid leukemia: NPM1 type B and D are only found in around 10% and 8% of NPM1 positive patients with AML, respectively, compared to 70% who have the NPM1 type A variant [9]; however, this is still a substantial number of patients and standardization should be considered if stable cell lines can be produced.